HSHoracio Sandoval-Trujillo

Horacio Sandoval-Trujillo

*This is an algorithmically generated author record based on publicly available information.

Horacio Sandoval-Trujillo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Degradation of Diclofenac and Ketoprofen by Bacillus Paralicheniformis HAS-1, Strain Isolated From a Soda Lake Sediment

    by Lorna Catalina Can-Ubando, Gabriela Ángeles-De Paz, Keila Isaac-Olivé, Elisabet Aranda, Ayixon Sánchez-Reyes, Horacio Sandoval-Trujillo, Ninfa Ramírez-Durán


  • Open Access

    Complete genome sequence of the Bacillus paralicheniformis strain HAS-1

    by Lorna Catalina Can-Ubando, Ninfa Ramírez-Durán, Elisabet Aranda, Gauddy Lizeth Manzanares-Leal, Ayixon Sánchez-Reyes, Gabriela Ángeles de Paz, Keila Isaac-Olivé, Horacio Sandoval-Trujillo

    We present the complete genome of the halotolerant strain Bacillus paralicheniformis HAS-1.


  • Open Access

    Antibacterial activity of Nocardia spp. and Streptomyces sp. on multidrug-resistant pathogens causing neonatal sepsis

    by Janette Berenice González-Nava, Gauddy Lizeth Manzanares-Leal, Luis Ángel Zapi-Colín, Sonia Dávila-Ramos, Horacio Sandoval-Trujillo, Ninfa Ramírez-Durán

    Neonatal sepsis leads to severe morbidity and occasionally death among neonates within the first week following birth, particularly in low- and middle-income countries. Empirical therapy includes antibiotics recommended by WHO. However, these have been ineffective against antimicrobial multidrug-resistant bacterial strains such as Klebsiella spp, Escherichia coli, and Staphylococcus aureus species. To counter this problem, new molecules and alternative sources of compounds with antibacterial activity are sought as options. Actinobacteria, particularly pathogenic strains, have revealed a biotechnological potential still underexplored. This study aimed to determine the presence of biosynthetic gene clusters and the antimicrobial activity of actinobacterial strains isolated from clinical cases against multidrug-resistant bacteria implicated in neonatal sepsis. In total, 15 strains isolated from clinical cases of actinomycetoma were used. PCR screening for the PKS-I, PKS-II, NRPS-I, and NRPS-II biosynthetic systems determined their secondary metabolite-producing potential. The strains were subsequently assayed for antimicrobial activity by the perpendicular cross streak method against Escherichia fergusonii Sec 23, Klebsiella pneumoniae subsp. pneumoniae H1064, Klebsiella variicola H776, Klebsiella oxytoca H793, and Klebsiella pneumoniae subsp. ozaenae H7595, previously classified as multidrug-resistant. Finally, the strains were identified by 16S rRNA gene sequence analysis. It was found that 100% of the actinobacteria had biosynthetic systems. The most frequent biosynthetic system was NRPS-I (100%), and the most frequent combination was NRPS-I and PKS-II (27%). All 15 strains showed antimicrobial activity. The strain with the highest antimicrobial activity was Streptomyces albus 94.1572, as it inhibited the growth of the five multidrug-resistant bacteria evaluated.


  • Open Access

    Genetic variability of the 16S rRNA gene of Nocardia brasiliensis, the most common causative agent of actinomycetoma in Latin America and the Caribbean

    by Michele Guadalupe Cruz-Medrano, Gauddy Lizeth Manzanares-Leal, Janette González-Nava, Pablo Antonio Moreno-Pérez, Horacio Sandoval-Trujillo, Ninfa Ramírez-Durán

    Mycetoma is a neglected tropical disease (NTD) declared by the World Health Organization (WHO) in 2016. It is characterized by the progressive growth of nodules and granulomatous lesions on the legs, arms, and trunk. It is potentially disfiguring and causes disability or amputations in working-age people from marginalized areas. The causative agents can be fungi (eumycetoma) or actinobacteria (actinomycetoma), the latter being the most common in America and Asia. Nocardia brasiliensis is the most important causal agent of actinomycetoma in the Americas. Taxonomic problems have been reported when identifying this species, so this study aimed to detect the 16S rRNA gene variations in N. brasiliensis strains using an in silico enzymatic restriction technique. The study included strains from clinical cases of actinomycetoma in Mexico, isolated from humans and previously identified as N. brasiliensis by traditional methods. The strains were characterized microscopically and macroscopically, then subjected to DNA extraction and amplification of the 16S rRNA gene by PCR. The amplification products were sequenced, and consensus sequences were constructed and used for genetic identification and in silico restriction enzyme analysis with the New England BioLabs® NEBcutter program. All study strains were molecularly identified as N. brasiliensis; however, in silico restriction analysis detected a diversity in the restriction patterns that were finally grouped and subclassified into 7 ribotypes. This finding confirms the existence of subgroups within N. brasiliensis. The results support the need to consider N. brasiliensis as a complex species.


  • Current Techniques For The Search For Natural Products In Actinobacteria

    by Ninfa Ramírez-Durán, Janette Berenice Gonzalez-Nava, Scarlett Alonso-Carmona, Gauddy Lizeth Manzanares-Leal, Horacio Sandoval-Trujillo

    The actinobacteria, also referred to as actinomycetes, have been the most widely used bacteria to produce industrial interest compounds due to their great biosynthetic capacity to generate structural diversity molecules. The actinobacteria with the most significant biosynthetic potential are the genus Streptomyces, Saccharopolyspora, and Micromonospora containing groups of biosynthetic genes such as polyketide synthase systems, non-ribosomal peptide synthase systems, terpenoid systems, ribosomally synthesized and post-translationally modified peptide systems, among others. This review focuses on genomic mining techniques and current helpful software to search for new natural products in actinobacteria. Currently, molecular techniques have been developed to improve the isolation of natural products, and bioinformatics programs, many are free to access, have been designed to analyze genes and microbial genomes that predict new molecule production. Thanks to these techniques, new natural products of industrial interest have been found in rare actinobacteria such as Nocardia and Rhodococcus.


  • Open Access

    Draft Genome Sequence of Saccharomonospora piscinae KCTC 19743 T , an Actinobacterium Containing Secondary Metabolite Biosynthetic Gene Clusters

    by Ninfa Ramírez-Durán, Rafael R. de la Haba, Blanca Vera-Gargallo, Cristina Sánchez-Porro, Scarlett Alonso-Carmona, Horacio Sandoval-Trujillo, Antonio Ventosa

    The draft genome sequence of Saccharomonospora piscinae KCTC 19743 T , with a size of 4,897,614 bp, was assembled into 11 scaffolds containing 4,561 open reading frames and a G+C content of 71.0 mol%. Polyketide synthase and nonribosomal peptide synthetase gene clusters, which are responsible for the biosynthesis of several biomolecules, were identified and located in different regions in the genome.